Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 4/20 | 0.68 |
| ▸ | PAX8 | Q06710 | 3/20 | 0.68 |
| ▸ | RAB9A | P51151 | 3/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.68 |
| ▸ | NPC1 | O15118 | 2/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 1/20 | 0.68 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.68 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.68 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.68 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.68 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.68 |
| ▸ | ATP12A | P54707 | 1/20 | 0.68 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.68 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.68 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7307864 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL21578272 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL11654361 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL4905392 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL7309200 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL8999665 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL11806297 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL7279420 | 1.00 | TP53 (0.68) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL8830696 | 0.89 | TP53 (0.56) | TP53PAX8RAB9ALMNASMN1; SMN2 | |
| SCHEMBL8830484 | 0.89 | TP53 (0.56) | TP53PAX8RAB9ALMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2195 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137707-A1 | METHODS OF MODULATING ATXN2 EXPRESSION | UNIV OF UTAH RESEARCH FOUNDATION (US) | 2026-05-21 | — | — | US | claimed |
| WO-2025151443-A1 | ENDOXIFEN FOR TREATMENT OF RARE CANCERS | ATOSSA THERAPEUTICS, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| EP-4536236-A2 | METHODS OF MODULATING ATXN2 EXPRESSION | University of Utah Research Foundation (US) | 2025-04-16 | — | — | EP | claimed |
| US-12097234-B2 | Extract containing oleandrin and method of production thereof | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-09-24 | — | — | US | claimed |
| US-20240293551-A1 | USE OF ST-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | BEIJING BAISHIHEKANG PHARMACEUTICAL TECHNOLOGY (BSJPHARMA) CO., LTD (CN) | 2024-09-05 | — | — | US | claimed |
| US-20240261312-A1 | Method and compositions for treating animal viral infections | PHOENIX BIOTECHNOLOGY, INC. (US) | 2024-08-08 | — | — | US | claimed |
| EP-4378483-A1 | USE OF ST-TYPE LIPID COMPOUNDS IN PREPARATION OF NUCLEIC ACID DELIVERY REAGENT AND RELATED PRODUCT | Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences (CN) | 2024-06-05 | — | — | EP | claimed |
| CN-118103046-A | Methods and compositions for treating viral infections in animals | 菲尼克斯生物技术公司 | 2024-05-28 | — | — | CN | claimed |
| EP-4333851-A1 | CORRECTION OF EXON SKIPPING IN MONOCYTE-DERIVED CELLS FOR IMPROVED IMMUNE RESPONSE | Schelling, D. Christopher (US) | 2024-03-13 | — | — | EP | claimed |
| WO-2024028324-A1 | MOLECULES FOR THE PREVENTION AND TREATMENT OF NEUROMUSCULAR DISORDERS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (FR) | 2024-02-08 | — | — | WO | claimed |
| EP-0003456-B1 | 3-AMINO-CARDENOLIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICINES CONTAINING THEM | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1984-11-07 | — | — | EP | claimed |
| EP-0078495-A1 | Process for the preparation of digitoxigenin | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-05-11 | — | — | EP | claimed |
| EP-0027023-A1 | Furyl intermediates of cardenolides, their synthesis and production of cardenolides and their isomers therefrom | Advance Biofactures Corporation (US) | 1981-04-15 | — | — | EP | claimed |
| US-4259240-A | Synthesis of furyl intermediates, and cardenolides and their isomers prepared therefrom | ADVANCE BIOFACTURES CORPORATION (US) | 1981-03-31 | — | — | US | claimed |
| US-4230621-A | TRACERS, HYDROXYPHENYLGLUTARIC ACID DERIVATIVES | E. R. SQUIBB & SONS, INC. (US) | 1980-10-28 | — | — | US | claimed |
| US-4064227-A | Radioimmunoassay method for the determination of cardiotonic glycosides | MALLINCKRODT, INC. (US) | 1977-12-20 | — | — | US | claimed |
| US-4060607-A | Cardenolide derivatives | ETABLISSEMENTS NATIVELLE S.A. (FR) | 1977-11-29 | — | — | US | claimed |
| US-4011212-A | 22-CYANO-24-NORCHOLANES | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-03-08 | — | — | US | claimed |
| US-3944541-A | 22-Cyano-24-norcholanes | AMERICAN HOME PRODUCTS CORPORATION (US) | 1976-03-16 | — | — | US | claimed |
| US-3933791-A | Obtention of digitoxigenin from neriifolin and 2'-acetylneriifolin | SYNTEX (U.S.A.) INC. (US) | 1976-01-20 | — | — | US | claimed |